Osteopontin regulates human glioma cell invasiveness and tumor growth in mice
Open Access
- 23 December 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 12 (1), 58-70
- https://doi.org/10.1093/neuonc/nop013
Abstract
Human malignant glioma cells are characterized by local invasion. In the present study, we investigated the role of osteopontin (OPN) in the invasiveness of human glioma cells isolated from grade IV tumors. We found that the expression levels of OPN in these cell lines paralleled matrix metalloproteinase-2 (MMP-2) expression and cell invasiveness potential. When U87MG glioma cells (with a high-OPN expression level) were stably transformed with specific small hairpin RNA to knock down OPN expression, MMP-2 secretion, cell invasiveness, and tumor growth in implanted brains were dramatically reduced. Conversely, forced expression of OPN in GBM-SKH glioma cells (which expressed OPN at a low level) increased MMP-2 secretion, enhanced cell invasiveness, and increased tumor growth in a rodent xenograft model. Expression of OPN was associated with increased expression of vimentin and decreased expression of glial fibrillary acidic protein. Treatment of glioma cells with 5-aza-2′-deoxycytidine (5-aza-dC) suppressed OPN expression in a concentration-dependent manner. Suppression of OPN expression by 5-aza-dC was associated with reductions in MMP-2 secretion, vimentin expression, cell invasion, intravasation, and tumor growth. These data suggest that OPN may play important roles in regulating cell invasion in glioma cells and that 5-aza-dC may serve as a therapeutic agent for human gliomas.This publication has 40 references indexed in Scilit:
- Down-regulation of osteopontin attenuates breast tumour progressionin vivoJournal of Cellular and Molecular Medicine, 2008
- Role of DNA methylation in the suppression of Apaf-1 protein in human leukaemiaOncogene, 2003
- Expression of extracellular matrix components in a highly infiltrative in vivo glioma modelActa Neuropathologica, 2003
- PROMOTION OF MALIGNANT ASTROCYTOMA CELL MIGRATION BY OSTEOPONTIN EXPRESSED IN THE NORMAL BRAIN: DIFFERENCES IN INTEGRIN SIGNALING DURING CELL ADHESION TO OSTEOPONTIN VS. VITRONECTINPublished by Hindawi Limited ,2002
- Suppression of intracranial human glioma growth after intramuscular administration of an adeno-associated viral vector expressing angiostatin.2002
- Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.2002
- Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vectorGene Therapy, 2002
- Osteopontin Stimulates Tumor Growth and Activation of Promatrix Metalloproteinase-2 through Nuclear Factor-κB-mediated Induction of Membrane Type 1 Matrix Metalloproteinase in Murine Melanoma CellsOnline Journal of Public Health Informatics, 2001
- Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTENOncogene, 2001
- Co‐expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cellsInternational Journal of Developmental Neuroscience, 1999